Introduction
Barbiturates were first introduced into medicine by Fisher and Von Mering in 1903, and they have been widely available for over half a century. With an epileptic population of 300,000, and an incidence of epilepsy in pregnancy of about 0-15%, it is surprising that neonatal barbiturate withdrawal has not received more attention in the U.K.
Case report
The mother, a 21-year-old primigravida with a 9-year history of epilepsy, had The diagnosis is facilitated by a history of barbiturate use in pregnancy, and such a history should be sought when neonatal behaviour is suggestive of withdrawal. In one recorded case (Bleyer and Marshall, 1972 ) the electroencephalogram demonstrated diffuse paroxysms of high voltage, slow-wave bursts, phenomena typical of adult barbiturate withdrawal, but in this infant it did not confirm the diagnosis.
Frequent feeds, adequate warmth and diminished environmental stimuli suffice in controlling symptoms in some infants, while others require sedation. Phenobarbital is effective, although the slow improvement noted by the present authors and others (Bleyer and Marshall, 1972) after initiation of therapy, suggests an elevated barbiturate tolerance. A dose in excess of the recommended anticonvulsant dose would probably be most effective. This should be reduced over a few months. The inability of chlorpromazine to prevent seizures in adult barbiturate withdrawal would seem to limit its use as the drug of first choice. Paregoric (camphorated tincture of opium) might be advantageous in the presence of diarrhoea. One of the first signs of improvement is the infant's ability to sleep for longer periods.
Other than failure of recognition, the rarity of this syndrome remains unexplained. In the adult, the onset and severity of withdrawal is to a certain extent dependent on the rate of excretion and degradation of the barbiturate. The rarity in the newborn may be partially explained by the prolonged half-life of barbiturate in many babies, consequent upon immature hepatic and renal function (Jailing et al., 1973) .
This retrospective survey suggests that antenatal exposure to barbiturates contributed to the high incidence of jitteriness and feeding difficulties. Not surprisingly, jitteriness (Hill et al. 1974) , vomiting (Erith, 1975) and deficient sucking (Kron, Stein and Goddard, 1966) have previously been reported following antenatal exposure to barbiturates.
It would appear that, while the complete withdrawal syndrome is uncommon, prolonged antenatal exposure to barbiturates may have a profound influence on neonatal behaviour. 
